LeMaitre Vascular, Inc. (LMAT)
77.65
-1.64
(-2.07%)
USD |
NASDAQ |
Nov 12, 16:00
77.66
+0.02
(+0.02%)
After-Hours: 20:00
LeMaitre Vascular Market Cap : 1.777B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.777B |
| November 11, 2026 | 1.814B |
| November 10, 2026 | 1.808B |
| November 09, 2026 | 1.857B |
| November 06, 2026 | 1.851B |
| November 05, 2026 | 1.910B |
| November 04, 2026 | 2.012B |
| November 03, 2026 | 1.844B |
| November 02, 2026 | 1.858B |
| October 30, 2026 | 1.851B |
| October 29, 2026 | 1.950B |
| October 28, 2026 | 1.895B |
| October 27, 2026 | 1.916B |
| October 26, 2026 | 1.928B |
| October 23, 2026 | 1.931B |
| October 22, 2026 | 1.951B |
| October 21, 2026 | 1.913B |
| October 20, 2026 | 1.907B |
| October 19, 2026 | 1.882B |
| October 16, 2026 | 1.848B |
| October 15, 2026 | 1.901B |
| October 14, 2026 | 1.889B |
| October 13, 2026 | 1.865B |
| October 12, 2026 | 1.896B |
| October 09, 2026 | 1.845B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.821B |
| October 07, 2026 | 1.813B |
| October 06, 2026 | 1.807B |
| October 05, 2026 | 1.852B |
| October 02, 2026 | 1.805B |
| October 01, 2026 | 1.834B |
| September 30, 2026 | 1.888B |
| September 29, 2026 | 1.895B |
| September 28, 2026 | 1.883B |
| September 25, 2026 | 1.864B |
| September 24, 2026 | 1.848B |
| September 23, 2026 | 1.842B |
| September 22, 2026 | 1.852B |
| September 21, 2026 | 1.811B |
| September 18, 2026 | 1.803B |
| September 17, 2026 | 1.817B |
| September 16, 2026 | 1.838B |
| September 15, 2026 | 1.835B |
| September 14, 2026 | 1.847B |
| September 11, 2026 | 1.843B |
| September 10, 2026 | 1.802B |
| September 09, 2026 | 1.817B |
| September 08, 2026 | 1.820B |
| September 04, 2026 | 1.845B |
| September 03, 2026 | 1.840B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 185.75B |
| AngioDynamics, Inc. | 508.46M |
| Alphatec Holdings, Inc. | 1.083B |
| AtriCure, Inc. | 2.850B |
| Baxter International, Inc. | 13.32B |
Market Cap Related Metrics
| PE Ratio | 28.70 |
| PS Ratio | 6.746 |
| PEG Ratio | 1.748 |
| Price to Book Value | 4.111 |
| Price to Free Cash Flow | 27.12 |
| Price | 77.65 |
| Earnings Yield | 3.48% |
| PEGY Ratio | 1.627 |
| Operating PE Ratio | 24.32 |
| Normalized PE Ratio | 28.70 |